Heart failure occurs when the heart is unable to pump blood as effectively as the body needs, either because it cannot contract with enough force, cannot relax and fill properly between beats, or both. Despite its name, heart failure does not mean the heart has stopped working — it means the heart needs support to work as well as it should, and with modern treatment, many people with heart failure lead active, stable lives for years.
Heart failure can occur at any age but becomes considerably more common with age, and it is generally a chronic, long-term condition rather than a single event — though it can also develop suddenly, and can worsen suddenly even in someone previously stable, which is when it becomes a genuine emergency. Treatment for heart failure has advanced considerably in recent years, with several newer medication classes now shown to meaningfully extend life and keep people out of hospital, on top of the more familiar treatments used for decades.
When the heart's pumping ability first begins to decline, the body activates several compensatory mechanisms to try to maintain adequate blood flow: the heart muscle can enlarge or thicken, the heart rate increases, and hormonal systems (including the renin-angiotensin-aldosterone system and the sympathetic nervous system) are activated to raise blood pressure and retain fluid, boosting the volume of blood the heart has to work with.
In the short term, these changes help maintain blood flow to vital organs. Over time, however, they become part of the problem rather than the solution — the enlarged heart muscle becomes less efficient, the persistently activated hormonal systems cause further strain and fluid retention, and this fluid retention is precisely what causes the fluid build-up in the lungs, liver, and legs that characterises worsening heart failure. This is also why many of the most effective heart failure medications work by specifically blocking these compensatory hormonal pathways — not by making the heart pump harder, but by interrupting the harmful cycle the body's own compensation creates.
Heart failure can be classified in two complementary ways: by which side of the heart is primarily affected, and, more importantly for guiding treatment, by ejection fraction — the percentage of blood the left ventricle pumps out with each contraction.
Left-Sided Heart Failure
Left-Sided Heart Failure The most common type. The left ventricle cannot pump efficiently, so blood backs up into the lungs, causing breathlessness and fluid build-up. Can be further divided by ejection fraction (see below).
Right-Sided Heart FailureOften triggered by left-sided failure, as the right ventricle has to work harder against the resulting congestion in the lungs. Blood backs up into the abdomen, legs, and feet, causing swelling and, in the abdomen, fluid accumulation (ascites).
Heart Failure with Reduced Ejection Fraction (HFrEF)Heart Failure with Reduced Ejection Fraction (HFrEF) Ejection fraction of 40% or below — the heart muscle has lost much of its ability to contract forcefully (a “pumping problem”). This is the category with the strongest evidence base for medication that meaningfully improves survival.
Heart Failure with Mildly Reduced Ejection Fraction (HFmrEF)
Ejection fraction of 41–49%, an intermediate category that shares features of, and treatment overlap with, both HFrEF and HFpEF.
Heart Failure with Preserved Ejection Fraction (HFpEF)
Heart Failure with Preserved Ejection Fraction (HFpEF) Ejection fraction of 50% or above — the heart contracts normally but the left ventricle is stiff and cannot relax and fill properly (a “filling problem”). More common in women, and often associated with high blood pressure, obesity, and diabetes.
Beyond the type of heart failure, doctors also grade how much it is limiting a person's daily life, using a widely used framework called the New York Heart Association (NYHA) functional classification. This matters because it guides treatment intensity and helps track whether someone is improving or worsening over time, independent of the specific ejection fraction measurement.